Ascentage Pharma Group International (AAPG) Treasury Shares (2023 - 2025)
Ascentage Pharma Group International (AAPG) posted quarterly Treasury Shares of $417479.1 for Q4 2025, up 37384.91% year-on-year from N/an in Q4 2024, and up 37384.91% on a QoQ basis from $1113.7 in Q4 2024.
Ascentage Pharma Group International (AAPG) Treasury Shares (2023 - 2025) Analysis & Trends
Ascentage Pharma Group International (AAPG) has reported Treasury Shares for 3 consecutive years, with $417479.1 the latest figure, recorded in Q4 2025.
- Quarterly Treasury Shares rose 37384.91% year-over-year to $417479.1 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $417479.1 (up 37384.91% YoY) and the FY2025 annual result came in at $423000.0, up 42200.0% from the prior year.
- Treasury Shares improved to $417479.1 in Q4 2025 per AAPG's latest filing, from $1113.7 in the prior quarter.
- Over the last five years, Treasury Shares for AAPG reached as high as $3.0 million in Q4 2023 and fell as low as $1113.7 in Q4 2024.
- A 3-year average of $1.1 million and a median of $417479.1 in 2025 frame the typical range for Treasury Shares.
- Annual changes were most pronounced in 2024 — Treasury Shares plunged 99.96% — and 2025, when it surged 37384.91%.
- Year by year, Treasury Shares stood at $3.0 million in 2023, then tumbled by 99.96% to $1113.7 in 2024, then jumped by 37384.91% to $417479.1 in 2025.
- According to Business Quant data, Treasury Shares over the past three periods registered $417479.1, $1113.7, and $3.0 million for Q4 2025, Q4 2024, and Q4 2023 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -21,709.08 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 265,401.92 |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | - |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 19.41 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 5.14 Mn |
| 10 | Ascentage Pharma Group International | 6.88 Bn | 6.54 Bn | - | 417,479.09 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 417,479.09 |
| Dec 31, 2025 | 417,479.09 |
| Dec 31, 2024 | 1,113.73 |
| Dec 31, 2024 | 1,113.73 |
| Dec 31, 2023 | 2.97 Mn |
| Dec 31, 2023 | 2.97 Mn |